Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX in Chinese Patients with Moderate to Severe Frown Lines
NCT01814670Phase 4Completed
- Sponsor
- Allergan
- Start
- Mar 2013
- Primary completion
- Jul 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of onabotulinumtoxinA in glabellar lines, sponsored by Allergan. Started Mar 2013; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT01814670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01814670.